TPL2 modulators (MRC/NIMR/MRCT)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameTPL2 modulators (MRC/NIMR/MRCT)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase 8 modulators
TargetsMitogen-activated protein kinase kinase kinase 8
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedical Research Council
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUk National Institute For Medical ResearchLifearcMedical Research Council
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A